This inventor holds 2 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Charles F. Thomas
Introduction
Charles F. Thomas is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in understanding and diagnosing infections caused by Pneumocystis carinii. With a total of 2 patents, his work has implications for both therapeutic development and patient care.
Latest Patents
One of his latest patents is focused on the Cdc2 protein kinase from Pneumocystis carinii. This invention describes a nucleic acid and corresponding polypeptide that aids in the regulation of the cell cycle in Pneumocystis carinii. Antibodies generated against a unique carboxyl-terminus region of the polypeptide have specific binding affinity for the P. carinii Cdc2 polypeptide. These antibodies are beneficial in diagnosing and monitoring P. carinii infection in patients. Additionally, the expression of the P. carinii Cdc2 polypeptide in cdc2-mutant yeast and other cdc2-mutant organisms provides a useful model for studying the life cycle of P. carinii and for identifying novel therapeutics.
Another patent by Charles F. Thomas involves a method for identifying inhibitors of the cdc2 protein kinase from Pneumocystis carinii. Similar to his previous patent, it describes a nucleic acid and corresponding polypeptide that aids in the regulation of the cell cycle. The antibodies generated against the unique carboxyl-terminus region of the polypeptide again demonstrate specific binding affinity for the P. carinii Cdc2 polypeptide, aiding in the diagnosis and monitoring of infections.
Career Highlights
Charles F. Thomas is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to contribute to advancements in medical science. His research has been pivotal in enhancing the understanding of Pneumocystis carinii and its impact on human health.
Collaborations
Throughout his career, Charles has collaborated with esteemed colleagues such as Andrew H. Limper and Edward B. Leof. These collaborations have further enriched his research and expanded the scope of his innovations.
Conclusion
Charles F. Thomas exemplifies the spirit of innovation in medical research. His patents and ongoing work contribute significantly to the understanding and treatment of Pneumocystis carinii infections
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile